177 related articles for article (PubMed ID: 231773)
1. [Evaluation of the effectiveness of 2-drug and multi-drug chemotherapy in primary lung cancer].
Durda M; Skublewski A; Patyra R; Ziemecka E
Pneumonol Pol; 1979; 47(7-8):603-7. PubMed ID: 231773
[No Abstract] [Full Text] [Related]
2. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
[No Abstract] [Full Text] [Related]
3. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results].
Pipino G; Germiniani R; Maione G; Fazio FM
Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792
[No Abstract] [Full Text] [Related]
4. [Polychemotherapy of small-cell lung cancer].
Krawczyk K; Krochmal M; Pawlicki M; Kulpa J
Pneumonol Pol; 1983 Feb; 51(2):101-5. PubMed ID: 6308583
[No Abstract] [Full Text] [Related]
5. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
[TBL] [Abstract][Full Text] [Related]
8. [Combined chemotherapy of bronchial carcinomas (author's transl)].
Karrer K; Pridun N; Denck H
Z Erkr Atmungsorgane; 1980; 155(1):21-40. PubMed ID: 6259843
[No Abstract] [Full Text] [Related]
9. Combined modality treatment of small cell carcinoma of the lung.
Feld R; Pringle JF; Evans WK; Keen CW; Quirt IC; Curtis JE; Baker MA; Yeoh JL; Deboer G; Brown TC
Arch Intern Med; 1981 Mar; 141(4):469-73. PubMed ID: 6260048
[TBL] [Abstract][Full Text] [Related]
10. [A study of two protocols of multiple chemotherapy in small round cell tumours of the lung (author's transl)].
Israël L; Breau JL; Depierre A; Choffel C; Lemarié E; Battesti JP
Rev Fr Mal Respir; 1981; 9(2):123-31. PubMed ID: 6166970
[No Abstract] [Full Text] [Related]
11. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
Livingston RB; Mira J; O'Bryan RM
Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
[No Abstract] [Full Text] [Related]
12. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
13. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
14. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
[No Abstract] [Full Text] [Related]
15. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
16. [Means of improving the chemoradiotherapy of small cell cancer of the lung].
Monakhov BV; Borisevich NV; Akyshbaev AA
Vopr Onkol; 1988; 34(6):718-21. PubMed ID: 2839938
[TBL] [Abstract][Full Text] [Related]
17. The role of chemotherapy in the treatment of lung cancer.
Selawry OS
Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
[No Abstract] [Full Text] [Related]
18. [Prevention of bronchopulmonary inflammation in patients with lung cancer receiving cytostatic therapy].
Viazitskiĭ PO; Iakovlev VN; Alekseev VG; Dmitriev IuK; Duganov VK
Klin Med (Mosk); 1988 Jun; 66(6):64-7. PubMed ID: 2460668
[No Abstract] [Full Text] [Related]
19. [Comparison of 2 regimens of chemotherapy of small cell carcinoma of the lung: modified Hansen method and the ACOM method].
Jassem J; Karnicka-Młodkowska H; Mierzewski P; Decker E; Krawczyk K; Lisowska B; Malak K; Słupek A; Sokół A; Sosnowski K
Pneumonol Pol; 1988 Apr; 56(4):142-51. PubMed ID: 2842737
[No Abstract] [Full Text] [Related]
20. [Effects of a combination chemotherapy "VEMA" consisting of vincristine, cyclophosphamide, methotrexate and ACNU in the treatment of small cell bronchogenic carcinoma].
Kojima T; Ito Y; Nakanishi F; Sugihara T; Nagata K; Kamiya O; Ohara K; Hoshino A
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1491-6. PubMed ID: 6307169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
